Structure, function, and regulation of the Hsp90 machinery
MM Biebl, J Buchner - Cold Spring Harbor perspectives …, 2019 - cshperspectives.cshlp.org
Heat shock protein 90 (Hsp90) is a molecular chaperone involved in the maturation of a
plethora of substrates (“clients”), including protein kinases, transcription factors, and E3 …
plethora of substrates (“clients”), including protein kinases, transcription factors, and E3 …
Modulation of protein–protein interactions for the development of novel therapeutics
I Petta, S Lievens, C Libert, J Tavernier… - Molecular Therapy, 2016 - cell.com
Protein–protein interactions (PPIs) underlie most biological processes. An increasing
interest to investigate the unexplored potential of PPIs in drug discovery is driven by the …
interest to investigate the unexplored potential of PPIs in drug discovery is driven by the …
Advances in the medical treatment of Cushing's syndrome
Cushing's syndrome is associated with multisystem morbidity and, when suboptimally
treated, increased mortality. Medical therapy is an option for patients if surgery is not …
treated, increased mortality. Medical therapy is an option for patients if surgery is not …
Identification of recurrent USP48 and BRAF mutations in Cushing's disease
J Chen, X Jian, S Deng, Z Ma, X Shou, Y Shen… - Nature …, 2018 - nature.com
Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete
adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism …
adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism …
Anticancer inhibitors of Hsp90 function: beyond the usual suspects
The 90-kDa heat-shock protein (Hsp90) is a molecular chaperone responsible for the
stability and function of a wide variety of client proteins that are critical for cell growth and …
stability and function of a wide variety of client proteins that are critical for cell growth and …
Cushing's disease
H Nishioka, S Yamada - Journal of clinical medicine, 2019 - mdpi.com
In patients with Cushing's disease (CD), prompt diagnosis and treatment are essential for
favorable long-term outcomes, although this remains a challenging task. The differential …
favorable long-term outcomes, although this remains a challenging task. The differential …
Genetic and epigenetic causes of pituitary adenomas
M Chang, C Yang, X Bao, R Wang - Frontiers in endocrinology, 2021 - frontiersin.org
Pituitary adenomas (PAs) can be classified as non-secreting adenomas, somatotroph
adenomas, corticotroph adenomas, lactotroph adenomas, and thyrotroph adenomas …
adenomas, corticotroph adenomas, lactotroph adenomas, and thyrotroph adenomas …
Molecular derangements and the diagnosis of ACTH-dependent Cushing's syndrome
LK Nieman - Endocrine Reviews, 2022 - academic.oup.com
Endogenous Cushing's syndrome (CS) is associated with morbidities (diabetes,
hypertension, clotting disorders) and shortens life because of infections, pulmonary …
hypertension, clotting disorders) and shortens life because of infections, pulmonary …
Genetics of Cushing's disease
J Simon, M Theodoropoulou - Journal of Neuroendocrinology, 2022 - Wiley Online Library
Corticotroph tumours are primarily sporadic monoclonal neoplasms and only rarely found in
genetic syndromes. Recurrent mutations in the ubiquitin specific protease 8 (USP8) gene …
genetic syndromes. Recurrent mutations in the ubiquitin specific protease 8 (USP8) gene …
Medical management of Cushing's syndrome: current and emerging treatments
Endogenous Cushing's syndrome is a chronic disease associated with increased morbidity
and mortality if not appropriately treated. Recurrence and/or persistence of …
and mortality if not appropriately treated. Recurrence and/or persistence of …